nature’s

Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy

Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE…

1 week ago

24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Natures Toughest Fiber

DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial…

2 months ago

Nature’s Miracle Holding Inc. (“NMHI”), Datavault AI (“DVLT”) and Harrison Global Holdings Inc. (“BLMZ) Join Forces to Launch the X Club for the Global XRP Community

ONTARIO, Calif., Sept. 22, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) along with Datavault AI Inc.(Nasdaq: DVLT) and Harrison…

2 months ago